Real-world effectiveness of upadacitinib induction therapy in Crohn's disease, with a focus on patients with concomitant IMIDs

被引：0
|
作者：
Gonzalez, A. Elosua [1 ]
Zabalza, L. [1 ]
Vicuna, M. [1 ]
Rubio, S. [1 ]
Nantes, O. [1 ]
Rodriguez, C. [1 ]
机构：
[1] Hosp Univ Navarra, Gastroenterol, Pamplona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1164
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0990
引用
收藏
页码：i1840 / i1840
页数：1
相关论文
共 50 条
  • [41] Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn's disease: A Belgian multi-centric refractory cohort
    Pavlidi, A.
    Verstockt, B.
    Vieujean, S.
    Desmedt, V
    Couturier, F.
    Rahier, J. F.
    Baert, F.
    Somers, M.
    Dewit, O.
    Bossuyt, P.
    Hoyois, A.
    Holvoet, T.
    Ouziel, R.
    Willandt, B.
    Lambrecht, G.
    Salame, M.
    Verreth, A.
    Lenfant, M.
    Franchimont, D.
    Cremer, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1776 - i1777
  • [42] Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Cleveland, Noa Krugliak
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1913 - +
  • [43] Real-World Clinical and Comparative Effectiveness of Infliximab in Pediatric Crohn's Disease
    Kappelman, Michael
    Bailey, Charles
    Crandall, Wallace
    Zhang, Peixin
    King, Eileen
    Joffe, Marshall M.
    Colletti, Richard B.
    Forrest, Christopher B.
    GASTROENTEROLOGY, 2013, 144 (05) : S146 - S146
  • [44] A MULTICENTER STUDY OF THE REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN CROHN'S DISEASE
    Askar, Manar
    Belani, Seema
    Devi, Jalpa
    Huang, Katherine
    Khan, Abdul
    Said, Hyder
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Fenster, Marc
    Ungaro, Ryan C.
    Yarur, Andres
    Deepak, Parakkal
    Johnson, Amanda M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1143 - S1144
  • [45] Upadacitinib therapy for Crohn’s disease
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 483 - 483
  • [46] Upadacitinib therapy for Crohn's disease
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (08) : 483 - 483
  • [47] Characteristics of Patients With Crohn's Disease Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufil
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S773 - S774
  • [48] Optimal Dosage of Upadacitinib in Crohn's Disease Patients: Experience from Real World Setting
    Juillerat, Pascal
    Martinho-Grueber, Maude
    Ruetsch, Roseline
    Moubayed, Hayssam
    Vulliemoz, Marianne
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2023, 153 : 26S - 26S
  • [49] Real-World Effectiveness of Advanced Therapies on Bowel Urgency in Patients With Crohn's Disease in the United States
    Lewis, James D.
    Maria Chan, Wai Man
    Moses, Richard E.
    Zhou, Xian
    Wang, Yitong
    Jha, Payal
    Gibble, Theresa H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S8 - S8
  • [50] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease
    Chen, M.
    Gao, X.
    Cao, Q.
    Zhang, X.
    Chen, Y.
    Hou, X.
    Zhong, J.
    Sun, Y.
    Phaleng, X.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1213 - I1213
12345